Nashine, Sonali
Cohen, Pinchas
Chwa, Marilyn
Lu, Stephanie
Nesburn, Anthony B
Kuppermann, Baruch D
Kenney, M Cristina
Article History
Received: 20 March 2017
Revised: 20 June 2017
Accepted: 22 June 2017
First Online: 20 July 2017
Competing interests
: PC: Consultant and stockholder of CohBar Inc.; BDK: Clinical research: Alcon, Allergan, Apellis, Genentech, GSK, Ophthotech, Regeneron; Consultant: Alcon, Allergan, Catalyst, Genentech, Novartis, Ophthotech, Regeneron; Recipient: Allergan, Genentech, Novartis, Regeneron. The remaining authors declare no conflict of interest.